MAPT and Alzheimer disease: We further show that members of M42, including SMOC1 and SPON1, were significantly increased in AD plasma and correlated to CSF levels of amyloid, tau and pTau as well as plasma pTau, suggesting that these proteins are related to AD pathophysiology in both brain and plasma.